Pricing & Access· June 1, 2026 · 12 min readIRA Part B drug negotiation: provider reimbursement risk under the buy-and-bill modelWhen Medicare negotiates physician-administered drug prices in 2028, the ASP-to-MFP shift could reduce provider add-on payments by...By Ran Chen#IRA Negotiation#Medicare Part B#Drug Pricing
Pricing & Access· May 22, 2026 · 12 min readASP lag after launch: why buy-and-bill economics can break in the first quartersWhy ASP lag can strain buy-and-bill margins after launch, and what access teams should model during the WAC-to-ASP reimbursement...By Ran Chen#Medicare Part B#ASP#Buy and Bill